The Lancet Revenue and Competitors
Estimated Revenue & Valuation
- The Lancet's estimated annual revenue is currently $104.5M per year.
- The Lancet's estimated revenue per employee is $303,750
Employee Data
- The Lancet has 344 Employees.
- The Lancet grew their employee count by 6% last year.
The Lancet Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $401.4M | 1180 | 15% | N/A | N/A |
#2 | $96M | 316 | 6% | N/A | N/A |
#3 | $12.9M | 59 | 5% | N/A | N/A |
#4 | $25.8M | 106 | -18% | N/A | N/A |
#5 | $15.1M | 69 | 6% | N/A | N/A |
#6 | $46.5M | 174 | 7% | N/A | N/A |
#7 | $29.9M | 123 | 3% | N/A | N/A |
#8 | $100.2M | 330 | 4% | N/A | N/A |
#9 | $33.8M | 139 | -7% | N/A | N/A |
#10 | $343.9M | 1011 | -1% | N/A | N/A |
What Is The Lancet?
The Lancet began as an independent, international weekly general medical journal founded in 1823 by Thomas Wakley. Since its first issue (October 5, 1823), the journal has strived to make science widely available so that medicine can serve and transform society, and positively impact the lives of people. Over the past two centuries, The Lancet has sought to address urgent topics in our society, initiate debate, put science into context, and influence decision makers around the world. The Lancet has evolved as a family of journals in the fields of child & adolescent health, diabetes and endocrinology, gastroenterology and hepatology, global health, HIV, haematology, infectious diseases, neurology, oncology, planetary health, psychiatry, public health, planetary health, and respiratory medicine. It retains at its core the belief that medicine must serve society, that knowledge must transform society, that the best science must lead to better lives. Learn more at - http://bit.ly/Lancet_LinkedIn The Lancet is a trade mark of RELX Intellectual Properties SA, used under license.
keywords:Healthcare,Pharmaceuticals
N/A
Total Funding
344
Number of Employees
$104.5M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
The Lancet News
The Lancet Respiratory Medicine. Close. This Journal. Back; Journal Home · Online First · Current Issue · All Issues · About the journal.
The Lancet Global Health. Close. This Journal. Back; Journal Home · Online First · Current Issue · All Issues · About the journal. Journals.
Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health...
Every year, a thick smog covers India’s capital New Delhi. Last week, it got so bad for the 20 million residents that authorities shut schools. New Delhi’s concentration of PM2.5 particles, which damage people’s lungs, is 34 times the World Health Organization’s (WHO) acceptable levels. The tox ...
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $69.1M | 344 | 0% | N/A |
#2 | $94.6M | 344 | -3% | N/A |
#3 | $104.5M | 344 | 7% | N/A |
#4 | $86.6M | 345 | 2% | N/A |
#5 | $94.9M | 345 | 8% | N/A |